Integer Completes Merger With Armstrong Bidco

Integer Holdings became a wholly owned subsidiary of Armstrong Parent, with shareholders receiving $127.00 in cash per share.

Updated on Nov. 17, 2026 in Corporate Finance

Integer Completes Merger With Armstrong Bidco

Integer Holdings Corporation completed its merger with Armstrong Bidco, Inc., a wholly owned subsidiary of Armstrong Parent, Inc., on November 17, 2026. Each outstanding share of common stock, other than certain excluded shares, was converted into the right to receive $127.00 in cash, without interest.

Why it matters

The merger makes Integer a private, wholly owned subsidiary, ending its public equity listing. The transaction also triggered make-whole and fundamental change provisions on its convertible senior notes, affecting noteholders' conversion economics.

The company disclosed a $127.00 per-share cash consideration and conversion rates that increased from 11.4681 to 11.7408 for 2028 notes and from 6.6243 to 8.1043 for 2030 notes during the make-whole window. The filing does not disclose aggregate note principal or total deal value.

The players

Integer Holdings Corporation

Integer Holdings is a Plano, Texas-based medical device contract manufacturer and developer that supplies components and outsourced manufacturing services to the medical technology industry.

The details

Holders may convert their notes from the effective date through 5:00 p.m. New York City time on January 8, 2027, after which each series' conversion rate reverts automatically to its pre-merger level. Noteholders are not entitled to require repurchase of their notes in connection with the merger, because the transaction is a merger event whose reference property consists solely of U.S. dollar cash.

Timeline

  1. February 3, 2023: Indenture governing the 2028 Notes dated.

  2. March 18, 2025: Indenture governing the 2030 Notes dated.

  3. August 2, 2026: Agreement and Plan of Merger dated.

  4. November 17, 2026: Merger completed and make-whole and fundamental changes occurred.

  5. January 8, 2027: Make-Whole Fundamental Change Period ends.

Market Dynamics

The take-private of Integer follows a pattern of medical device contract manufacturers leaving public markets for private ownership. Such transactions shift capital structure decisions away from public disclosure requirements.

Shareholders who held Integer common stock receive $127.00 in cash per share and no longer hold equity in a publicly traded company. Noteholders who wish to benefit from the make-whole conversion increase must convert by 5:00 p.m. New York City time on January 8, 2027.

The takeaway

For convertible noteholders, the window to convert at the enhanced make-whole rate closes on January 8, 2027, so timing matters. Investors in similar pending take-privates should check each indenture's conversion and repurchase terms.

Further reading

Explore more Corporate Finance coverage of mergers, acquisitions and convertible debt events.